BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25305080)

  • 1. Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice.
    Kurosawa M; Matsumoto G; Kino Y; Okuno M; Kurosawa-Yamada M; Washizu C; Taniguchi H; Nakaso K; Yanagawa T; Warabi E; Shimogori T; Sakurai T; Hattori N; Nukina N
    Hum Mol Genet; 2015 Feb; 24(4):1092-105. PubMed ID: 25305080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.
    Tomás-Zapico C; Díez-Zaera M; Ferrer I; Gómez-Ramos P; Morán MA; Miras-Portugal MT; Díaz-Hernández M; Lucas JJ
    Hum Mol Genet; 2012 Feb; 21(3):495-510. PubMed ID: 22045698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease.
    Ribeiro FM; Devries RA; Hamilton A; Guimaraes IM; Cregan SP; Pires RG; Ferguson SS
    Hum Mol Genet; 2014 Apr; 23(8):2030-42. PubMed ID: 24282028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
    Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
    Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine 403-phosphorylated p62/SQSTM1 immunoreactivity in inclusions of neurodegenerative diseases.
    Kurosawa M; Matsumoto G; Sumikura H; Hatsuta H; Murayama S; Sakurai T; Shimogori T; Hattori N; Nukina N
    Neurosci Res; 2016 Feb; 103():64-70. PubMed ID: 26302676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.
    Wang YL; Liu W; Wada E; Murata M; Wada K; Kanazawa I
    Neurosci Res; 2005 Nov; 53(3):241-9. PubMed ID: 16095740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of p38 Mitogen-Activated Protein Kinase Ameliorates HAP40 Depletion-Induced Toxicity and Proteasomal Defect in Huntington's Disease Model.
    Huang ZN; Chen JM; Huang LC; Fang YH; Her LS
    Mol Neurobiol; 2021 Jun; 58(6):2704-2723. PubMed ID: 33492644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
    Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
    J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.
    Zheng S; Clabough EB; Sarkar S; Futter M; Rubinsztein DC; Zeitlin SO
    PLoS Genet; 2010 Feb; 6(2):e1000838. PubMed ID: 20140187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3.
    Zeng L; Wang B; Merillat SA; Minakawa EN; Perkins MD; Ramani B; Tallaksen-Greene SJ; Costa MDC; Albin RL; Paulson HL
    Neurobiol Dis; 2015 Oct; 82():281-288. PubMed ID: 26141599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington's disease.
    Rué L; López-Soop G; Gelpi E; Martínez-Vicente M; Alberch J; Pérez-Navarro E
    Neurobiol Dis; 2013 Apr; 52():219-28. PubMed ID: 23295856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IKKβ slows Huntington's disease progression in R6/1 mice.
    Ochaba J; Fote G; Kachemov M; Thein S; Yeung SY; Lau AL; Hernandez S; Lim RG; Casale M; Neel MJ; Monuki ES; Reidling J; Housman DE; Thompson LM; Steffan JS
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10952-10961. PubMed ID: 31088970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice.
    Schilling G; Savonenko AV; Klevytska A; Morton JL; Tucker SM; Poirier M; Gale A; Chan N; Gonzales V; Slunt HH; Coonfield ML; Jenkins NA; Copeland NG; Ross CA; Borchelt DR
    Hum Mol Genet; 2004 Aug; 13(15):1599-610. PubMed ID: 15190011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light and electron microscopic characterization of the evolution of cellular pathology in the R6/1 Huntington's disease transgenic mice.
    Bayram-Weston Z; Jones L; Dunnett SB; Brooks SP
    Brain Res Bull; 2012 Jun; 88(2-3):104-12. PubMed ID: 21801812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model.
    Chou SY; Lee YC; Chen HM; Chiang MC; Lai HL; Chang HH; Wu YC; Sun CN; Chien CL; Lin YS; Wang SC; Tung YY; Chang C; Chern Y
    J Neurochem; 2005 Apr; 93(2):310-20. PubMed ID: 15816854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease.
    Wanderer J; Morton AJ
    Histochem Cell Biol; 2007 May; 127(5):473-84. PubMed ID: 17285342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice.
    Yu ZX; Li SH; Nguyen HP; Li XJ
    Hum Mol Genet; 2002 Apr; 11(8):905-14. PubMed ID: 11971872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein.
    Bauer PO; Goswami A; Wong HK; Okuno M; Kurosawa M; Yamada M; Miyazaki H; Matsumoto G; Kino Y; Nagai Y; Nukina N
    Nat Biotechnol; 2010 Mar; 28(3):256-63. PubMed ID: 20190739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.